Export 169 results:
Filters: First Letter Of Last Name is G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Ryan, M., Gurian P., Haas C., Rose J., & Duzinski P. (2013).  Acceptable microbial risk: Cost-benefit analysis of a boil water order for Cryptosporidium. Journal of the American Water Works Association.
Ryan, M., Gurian P., Haas C., Rose J., & Duzinski P. (2013).  Acceptable microbial risk: Cost-benefit analysis of a boil water order for Cryptosporidium. Journal of the American Water Works Association.
Valdramidis, V. Panagiotis, Bernaerts K., Van Impe J. Frans, & Geeraerd A. Helena (2005).  An alternative approach to non-log-linear thermal microbial inactivation: modelling the number of log cycles reduction with respect to temperature. Food Technology and Biotechnology. 43, 321–327.
Shepard, C.. W., Soriano-Gabarro M.., Zell E.. R., Hayslett J.., Lukacs S.., Goldstein S.., et al. (2002).  Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence. Emerging infectious diseases. 8, 10.
Cole, DW., Cole R., & Gaydos SJ. (2009).  Aquaculture: Environmental, toxicological, and health issues. International Journal of Hygiene and Environmental Health.
Sato, M. I., Galvani A. T., Padula J. A., Nardocci A. C., Lauretto M. S., Razzolini M. T., et al. (2013).  Assessing the infection risk of Giardia and Cryptosporidium in public drinking water delivered by surface water systems in Sao Paulo State, Brazil. Science of the Total Environment. 442,
Jenkins, MB., Anguish L., Bowman D., Walker M., & Ghiorse W. (1997).  Assessment of a dye permeability assay for determination of inactivation rates of Cryptosporidium parvum oocysts.
Tribble, D. R., Baqar S., Scott D. A., Oplinger M. L., Trespalacios F., Rollins D., et al. (2010).  Assessment of the Duration of Protection in Campylobacter jejuni Experimental Infection in Humans. Infection and Immunity. 78, 4.
McQuaig, S., Griffith J., & Harwood V. J. (2012).  Association of fecal indicator bacteria with human viruses and microbial source tracking markers at coastal beaches impacted by nonpoint source pollution. Applied and environmental microbiology. 78, 6423–6432.
B
Gurian, P.. L., Small M.. J., Lockwood J.. R., & Schervish M.. J. (2001).  Benefit-cost estimation for alternative drinking water maximum contaminant levels. Water Resources Research. 37, 8.
Nappier, SP., Graczyk TK., & Schwab KJ. (2008).  Bioaccumulation, retention, and depuration of enteric viruses by Crassostrea virginica and Crassostrea ariakensis oysters.
Bronze, MS., & Greenfield RA. (2005).  Biodefence Principles and Pathogens.
Jernigan, J.. A., Stephens D.. S., Ashford D.. A., Omenaca C.., Topiel M.. S. >, Galbraith M.., et al. (2001).  Bioterrorism Related Inhalational Anthrax: The First 10 Cases Reported in the United States. Emerging Infectious Diseases. 7, 933-944.
Jernigan, J.. A., Stephens D.. S., Ashford D.. A., Omenaca C.., Topiel M.. S. >, Galbraith M.., et al. (2001).  Bioterrorism Related Inhalational Anthrax: The First 10 Cases Reported in the United States. Emerging Infectious Diseases. 7, 933-944.
Jernigan, J.. A., Stephens D.. S., Ashford D.. A., Omenaca C.., Topiel M.. S. >, Galbraith M.., et al. (2001).  Bioterrorism Related Inhalational Anthrax: The First 10 Cases Reported in the United States. Emerging Infectious Diseases. 7, 933-944.
Jernigan, J. A., Stephens D. S., Ashford D. A., Omenaca C., Topiel M. S., Galbraith M., et al. (2001).  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.. Emerging infectious diseases. 7, 933.
C
Mafart, P., Couvert O., Gaillard S., & Leguérinel I. (2002).  On calculating sterility in thermal preservation methods: application of the Weibull frequency distribution model. International journal of food microbiology. 72, 107–113.
Green, K. (2013).  Caliciviridae: The Noroviruses.
Tribble, D. R., Baqar S., Carmolli M. P., Porter C., Pierce K. K., Sadigh K., et al. (2009).  Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clinical infectious diseases. 49, 1512–1519.
Tribble, D.. R., Baqar S.., Carmolli M.. P., Porter C.., Pierce K.. K., Sadigh K.., et al. (2009).  Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 49, 1512-1519.
Tribble, D. R., Baqar S., Carmolli M. P., Porter C., Pierce K. K., Sadigh K., et al. (2009).  Campylobacter jejuni Strain CG8421: A Refined Model for the Study of Campylobacteriosis and Evaluation of Campylobacter Vaccines in Human Subjects. Clinical Infectious Diseases. 49, 10.
Tribble, D. R., Baqar S., Carmolli M. P., Porter C., Pierce K. K., Sadigh K., et al. (2009).  Campylobacter jejuni Strain CG8421: A Refined Model for the Study of Campylobacteriosis and Evaluation of Campylobacter Vaccines in Human Subjects. Clinical Infectious Diseases. 49, 10.
Linam, W. M., & Gerber M. A. (2007).  Changing epidemiology and prevention of Salmonella infections. The Pediatric Infectious Disease Journal. 26(8), 
Hamory, B.. H., Couch R.. B., G., Jr D. R., Black S.. H., & Knight V.. (1972).  Characterization of the infectious unit for man of two respiratory viruses. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.).. 139, 3.
Casanova, LM., & Gerba CP. (2001).  Chemical and microbial characterization of household graywater.